Ilona Gomez
Family · Thornton, CONPI 1093441677
Payments from drug & device makers
Across 64 payments — averaging $25.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$230
- Astellas Pharma US Inc$169
- Exelixis Inc.$117
- Caris MPI, Inc.$108
- Genentech USA, Inc.$91
- EMD Serono, Inc.$80
- plus $839 from 23 others
What the payments were for
- Food & beverage$1,633100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 11 | $230 |
| Astellas Pharma US Inc | 7 | $169 |
| Exelixis Inc. | 3 | $117 |
| Caris MPI, Inc. | 3 | $108 |
| Genentech USA, Inc. | 4 | $91 |
| EMD Serono, Inc. | 2 | $80 |
| Daiichi Sankyo Inc. | 3 | $74 |
| Sobi, Inc | 3 | $66 |
| AbbVie | 2 | $60 |
| Merck | 3 | $57 |
| Gilead | 2 | $52 |
| Johnson & Johnson | 2 | $51 |
| Eisai Inc. | 2 | $49 |
| AstraZeneca(2 entities) | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Tersera Therapeutics LLC | 1 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $32 |
| E.r. Squibb & Sons, L.L.C. | 1 | $30 |
| Azurity Pharmaceuticals, Inc. | 1 | $29 |
| Bayer | 1 | $28 |
| Myriad Genetic Laboratories, Inc. | 1 | $27 |
| Puma Biotechnology, Inc. | 1 | $27 |
| Genmab U.S., Inc. | 1 | $24 |
| Seagen Inc. | 1 | $24 |
| G1 Therapeutics, Inc. | 1 | $23 |
| Mirati Therapeutics, Inc. | 1 | $21 |
| Sanofi | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $17 |
How this compares
$1,633 in reported general payments places this provider in the 85th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $15,220 |
| Oxycodone Hcl | 39 | $1,636 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 12 | $1,446 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 26 | $807 |
| Morphine Sulfate ErMorphine Sulfate | 24 | $671 |
| Anastrozole | 76 | $607 |
| Ondansetron OdtOndansetron | 11 | $357 |
| Olanzapine | 15 | $184 |
| Gabapentin | 16 | $179 |
| Letrozole | 13 | $156 |
| Lorazepam | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other family in Thornton
- Teal MeffordThornton$63K
- Lauren BernatisThornton$17K
- Mackenzie CourtneyThornton$7K
- Laura GrahamLakewood$1.6M
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.